Related Experiment Videos
Immunity induced by live attenuated Salmonella vaccines
C E Hormaeche1, H S Joysey, L Desilva
1Department of Pathology, University of Cambridge, UK.
Research in Microbiology
|September 1, 1990
Summary
Salmonella aroA live vaccines show varying protection levels in mice. Salmonella typhimurium SL3261 offers strong protection, but specificity is influenced by bacterial background, not just LPS antigens.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Live attenuated Salmonella aroA vaccines are investigated for their protective efficacy.
- Understanding vaccine-induced immunity and specificity is crucial for developing effective Salmonella vaccines.
Purpose of the Study:
- To evaluate the degree and specificity of protection conferred by Salmonella aroA live vaccines in BALB/c mice.
- To determine the role of lipopolysaccharide (LPS) antigens in cross-protection against different Salmonella serotypes.
Main Methods:
- Mice were immunized intravenously with Salmonella typhimurium, Salmonella enteritidis, or Salmonella dublin aroA vaccines.
- Animals were challenged orally with virulent Salmonella strains three months post-vaccination.
- Protection levels were assessed based on lethal dose 50 (LD50) values and challenge strain characteristics.
Main Results:
- Salmonella typhimurium aroA SL3261 provided robust protection against homologous challenge (over 10,000 x LD50).
- Protection was highly specific, with limited cross-protection against Salmonella enteritidis (0-9) despite similar virulence.
- Specificity appeared more dependent on the Salmonella background than on O-antigen factors (4 or 9).
Conclusions:
- Salmonella typhimurium aroA SL3261 is a highly effective vaccine candidate, but its protective specificity is complex.
- The primary O-specific antigen may not be the main determinant of protection.
- Further research is needed to identify the key antigens responsible for protective immunity in Salmonella vaccines.